850 volunteers join hunt for earliest Alzheimer's clues
NCT ID NCT03140865
First seen Apr 02, 2026 · Last updated Jun 19, 2026 · Updated 11 times
Summary
This study follows 850 adults with normal cognition or mild memory issues to identify early risk factors for Alzheimer's disease. Researchers will track changes in memory, brain scans, and spinal fluid markers over time, with a special focus on how blood sugar and insulin problems may contribute. The goal is to better understand the disease's earliest stages to improve future prevention and treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wake Forest Baptist Health
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help identify early warning signs and risk factors for Alzheimer's, guiding future prevention or treatment strategies.
What could go wrong
This is an observational study, not testing a treatment. It may not directly lead to new therapies, and results may take years to impact patient care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.